Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-19T22:48:10.323Z Has data issue: false hasContentIssue false
  • English
  • Français

Dietary cholesterol, heart disease risk and cognitive dissonance

Published online by Cambridge University Press:  09 January 2014

Donald J. McNamara
Donald J. McNamara*
Affiliation:
Eggs for Health Consulting, 5905 Cozumel Pl., Las Vegas, NV 89131, USA
*
Corresponding author: D. J. McNamara, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

In the 1960s, the thesis that dietary cholesterol contributes to blood cholesterol and heart disease risk was a rational conclusion based on the available science at that time. Fifty years later the research evidence no longer supports this hypothesis yet changing the dietary recommendation to limit dietary cholesterol has been a slow and at times contentious process. The preponderance of the clinical and epidemiological data accumulated since the original dietary cholesterol restrictions were formulated indicate that: (1) dietary cholesterol has a small effect on the plasma cholesterol levels with an increase in the cholesterol content of the LDL particle and an increase in HDL cholesterol, with little effect on the LDL:HDL ratio, a significant indicator of heart disease risk, and (2) the lack of a significant relationship between cholesterol intake and heart disease incidence reported from numerous epidemiological surveys. Over the last decade, many countries and health promotion groups have modified their dietary recommendations to reflect the current evidence and to address a now recognised negative consequence of ineffective dietary cholesterol restrictions (such as inadequate choline intake). In contrast, health promotion groups in some countries appear to suffer from cognitive dissonance and continue to promote an outdated and potentially hazardous dietary recommendation based on an invalidated hypothesis. This review evaluates the evidence for and against dietary cholesterol restrictions and the potential consequences of such restrictions.

Keywords

Dietary cholesterolNutrition research methodsEggsHeart disease risk
Type
Conference on ‘Dietary strategies for the management of cardiovascular risk’
Information
Proceedings of the Nutrition Society , Volume 73 , Issue 2 , May 2014 , pp. 161 - 166
Copyright
Copyright © The Author 2014 

The development of a hypothesis

In 1968, the American Heart Association added a recommendation to restrict dietary cholesterol to <300 mg/d to its dietary guidelines for those at high risk for heart disease, and recommended a specific restriction on egg consumption to no more than three whole eggs per week( 1 ). There are two interesting points regarding these recommendations. First, there was no scientific rationale or justification for selecting 300 mg/d as the limit for dietary cholesterol (other than that the average US intake at the time was 580 mg/d and that 300 mg/d would represent a significant decrease in consumption). Second, of all the dietary recommendations, the egg restriction was the only food-specific restriction in the set of recommendations made by the American Heart Association. Understandably, it was difficult in 1968 to discuss the various dietary sources of total and saturated fats since consumers had little knowledge on this issue and nutrition facts panels had not yet been added to every food item. The semantic relationship between dietary cholesterol and serum cholesterol (i.e. ‘cholesterol in food equals cholesterol in the blood’) was a concept that could be simply expressed to the general public and would in effect encourage people to reduce animal products in the diet which happened to be the most significant sources of dietary saturated fat, with one exception … the egg. While high in cholesterol, the egg contains a relatively modest 1·5 g saturated fat per 50 g egg. One of the consequences of this focus on dietary cholesterol and eggs was that the egg became the icon for both high dietary cholesterol and high blood cholesterol and, even if the evidence for this relationship was weak, the message was simple and easily conveyed by health professionals not only to their patients at high risk for heart disease but also to the general public.

Once the dietary cholesterol and egg restrictions became part of the ‘Prudent Diet’ approach to heart disease prevention, there was little room for argument or questioning of the policy, even from a scientific or research perspective. There were a number of outspoken critics of these early dietary cholesterol and egg guidelines, but for the most part the naysayers were marginalised and discounted (for a fascinating history of the diet–heart disease battles see Good Calories, Bad Calories by Gary Taubes( Reference Taubes 2 )). For many sceptics in the scientific community, the dietary cholesterol raises blood cholesterol increasing heart disease hypothesis went from a thesis needing to be proven to a fact which now required application of reverse onus (i.e. now it needed to be proven that dietary cholesterol did not cause heart disease) which was an insurmountable obstacle and mostly set aside in favour of more achievable objectives. It has taken 50 years of research to undo the effects of those early condemnations and the ‘cholesterolphobia’ much of the world suffered from for decades.

The undoing of this hypothesis has come about through advances in both our understanding of the intricacies involved in the diet–heart disease relationship and through research progress in more precisely defining the various risk factors for heart disease and how they are affected by dietary factors. As in all studies of the relationships between diet and health, the same three lines of evidence used to establish the dietary cholesterol restriction were used to test the validity of the dietary cholesterol–heart disease relationship: animal model studies, analysis of epidemiological survey data and clinical interventions.

Animal model studies

Feeding cholesterol to rabbits results in pronounced dyslipidaemia and the development of atherosclerosis( Reference Anitschkow and Chalatow 3 ). Feeding cholesterol to a dog or rat has little, if any, effect on plasma cholesterol levels. To develop hypercholesterolaemia in some primate species it is necessary to feed the human cholesterol equivalent of 3000 mg/d. The majority of animal species, when fed a physiologically meaningful amount of cholesterol in the diet, experience little change in their plasma cholesterol profile due to appropriate metabolic feedback mechanisms. When cholesterol is fed, endogenous cholesterol synthesis is suppressed and bile acid synthesis and excretion is increased( Reference Dietschy 4 ). These compensatory mechanisms are sufficient to maintain a steady-state level of plasma cholesterol with no change in atherosclerotic risk. Thus, the quandary becomes which animal model best mimics the human condition. Many investigators would contend that probably no animal model best mimics the human response to dietary cholesterol for a number of reasons: differences in the plasma lipoprotein profile, differences in the factors involved in lipoprotein remodelling, species differences in the tissue distribution of endogenous cholesterol synthesis and sterol excretion patterns, variations in plasma metabolism and remodelling of the various lipoproteins and differences between species in the response to other dietary factors( Reference Fernandez, Wilson and Conde 5 , Reference Fernandez 6 ). For virtually all animal species, intake of physiological levels of cholesterol has no measurable effects on plasma cholesterol levels or CVD development. Animal model studies can make significant contributions to our knowledge of the processes of atherogenesis, but have very limited value in modelling CVD risk factor responses to dietary factors.

Epidemiological survey data

In 1968, the use of simple correlation analyses showed that both dietary cholesterol and dietary saturated fat were related to elevated plasma cholesterol levels and heart disease risk. Unfortunately, since both are found in animal products, they are significantly related to each other. Analysis of epidemiological survey data using multivariant analysis indicated that while saturated fat was independently related to heart disease risk, the significant relationship for dietary cholesterol was lost once the covariance with saturated fat was accounted for( Reference Hegsted and Ausman 7 , Reference Kromhout, Menotti and Bloemberg 8 ). As noted by Ravnskov( Reference Ravnskov 9 ), in eleven reports from the prospective and retrospective epidemiological studies there were no differences in dietary cholesterol intakes between cases and controls. And when applied to eggs, which have high cholesterol content but are relatively low in saturated fat, there was no significant relationship between egg intake and heart disease risk. Across cultures there is no significant relationship between per capita egg intake and CVD mortality rates( Reference Lee and Griffin 10 , Reference McNamara 11 ).

A number of studies have looked specifically at the relationship between egg consumption and either plasma cholesterol levels or heart disease risk within populations( Reference Dawber, Nickerson and Brand 12 – Reference Rong, Chen and Zhu 19 ). These studies have consistently shown that egg intake is not related to either plasma cholesterol levels or to heart disease risk in men or women( Reference Kritchevsky and Kritchevsky 20 , Reference Kritchevsky 21 ). In these studies, the relative risk for CHD was the same whether one ate one egg a week or one egg a day. These findings are consistent with the body of epidemiological analysis reporting that dietary cholesterol is unrelated to heart disease risk within populations( Reference Lee and Griffin 10 , Reference McNamara 11 , Reference McNamara, Sim, Nakai and Guenter 22 ). Recent studies investigating the effects of dietary lipids on subclinical atherosclerosis have also reported the absence of a relationship between dietary cholesterol intakes and mean carotid intimal medial thickness( Reference Merchant, Kelemen and de Koning 23 ).

In a recent meta-analysis of prospective cohort studies on the relationship between egg intake and CHD (3 081 269 person years, 5847 cases) and stroke (4 148 095 person years, 7579 cases), Rong et al. ( Reference Rong, Chen and Zhu 19 ) reported that there was no evidence of an association between egg consumption and risk of CHD or stroke (P=0·67). The relative risk of CHD for an increase of one egg consumed per day was 0·99 and for stroke 0·91. Simply put, analysis of decades of epidemiological data fails to find a relationship between egg intake and heart disease risk.

Clinical interventions

In the early days of metabolic ward studies on the effects of dietary factors on plasma cholesterol levels, patients were often fed liquid formula diets which allowed the researchers more precise control over the fat and cholesterol composition of test diets. Unfortunately, this new degree of control led many researchers to develop dietary cholesterol challenges that used pharmacological (rather than physiologically relevant) doses of 1000–4000 mg/d added to liquid diets with 40 % energy as coconut oil. This, of course, resulted in increased plasma cholesterol levels as the endogenous cholesterol metabolic capacity was overwhelmed and the normal feedback regulatory mechanisms failed to compensate( Reference McNamara, Kolb and Parker 24 , Reference McNamara 25 ). In addition, virtually all of the earlier studies used to justify the dietary cholesterol restriction used total plasma cholesterol levels as the surrogate marker for assumed changes in heart disease risk.

As the pattern of research studies shifted from formula feeding to solid foods and more rational, and physiologically relevant, cholesterol intakes, and the measured variables shifted from total to lipoprotein cholesterol levels, the evidence supporting the atherogenicity of dietary cholesterol progressively weakened. However, a consistent finding from study after study was the high degree of variability in plasma cholesterol responses to dietary cholesterol challenges between patients( Reference McNamara, Kolb and Parker 24 ). In order to explain this variability, and its significance in the dietary cholesterol – heart disease question, it is necessary to consider the inter-individual differences in cholesterol metabolism.

Cholesterol synthesis is a function of body weight, approximately 12 mg/kg-d. Therefore, changes in plasma cholesterol with the same dietary cholesterol challenge will differ for individuals having different body weights. Studies also indicate that the fractional absorption rate for cholesterol is highly variable, ranging from 20 to 80 %, with an average of 55 %( Reference McNamara 26 ). Based on these considerations, it is easy to understand why feeding an additional 500 mg cholesterol to a 100 kg male with a fractional absorption rate of 20 % will have a very different effect on plasma cholesterol levels as compared with the effects of the same dietary cholesterol challenge to a 50 kg female with an absorption rate of 80 %. Only a limited number of cholesterol feeding studies have adjusted for differences in body weights and fractional absorption rates between patients( Reference McNamara, Kolb and Parker 24 , Reference McNamara 26 ). Numerous analyses have shown that the average weight-adjusted plasma cholesterol response to a 100 mg/d increase in dietary cholesterol in a 70 kg individual is an increase in plasma total cholesterol of 2·4 mg/dl (0·062 mm/l) with increases in both the LDL cholesterol (1·9 mg/dl, 0·049 mm/l) and HDL cholesterol (0·4 mg/dl, 0·010 mm/l)( Reference McNamara 25 , Reference Clarke, Frost and Collins 27 – Reference Weggemans, Zock and Katan 30 ). These studies indicate that while adding cholesterol does have a small effect on plasma cholesterol levels, there is little if any change in the LDL:HDL cholesterol ratio, which is also an important determinant of CVD risk( Reference Herron, Vega-Lopez and Conde 31 – Reference Fernandez and Webb 33 ). Data also indicate that the changes in LDL cholesterol levels with cholesterol feeding are not due to changes in the number of LDL particles, but rather due to changes in the cholesterol content of these particles. Therefore, cholesterol feeding results in less-atherogenic large, buoyant LDL( Reference Herron, Lofgren and Sharman 34 ) rather than the more atherogenic small, dense LDL particles( Reference Williams, Superko and Haskell 35 ). With little effect on the LDL:HDL cholesterol ratio( Reference Fernandez 36 , Reference Herron and Fernandez 37 ) or on LDL particle number( Reference Hsia, Otvos and Rossouw 38 ) in both responders and non-responders to dietary cholesterol, dietary cholesterol has little effect on CVD risk, as documented by various epidemiological survey analyses( Reference Kritchevsky and Kritchevsky 20 , Reference Kritchevsky 21 ).

Do no harm

Restricting affordable, high-quality, nutrient-rich foods such as eggs from the diet because of their cholesterol content is not risk free. Affordable sources of high-quality animal protein in the diet, especially foods such as eggs that are widely available and easy to cook, chew and digest, are of significant importance for growth and development as well as for maintaining lean muscle tissue mass in the elderly( Reference Houston, Nicklas and Ding 39 ). Eggs are also an excellent source of choline( Reference Zeisel 40 ), an essential nutrient that has been shown to be inadequate in the diets of most adults in the USA( Reference Yonemori, Lim and Koga 41 ). Choline plays an important role in fetal and neonatal brain development( Reference Zeisel and Niculescu 42 ) and inadequate choline intake during pregnancy increases the risk for neural tube defects such as spina bifida( Reference Shaw, Carmichael and Yang 43 , Reference Shaw, Finnell and Blom 44 ). Choline intake is also associated with decreased plasma levels of homocysteine and inflammatory factors, both of which are related to increased CVD risk( Reference Detopoulou, Panagiotakos and Antonopoulou 45 , Reference Konstantinova, Vollset and Berstad 46 ).

Recent studies have reported negative relationships between dietary choline and breast cancer incidence and mortality as well as a relationship between egg intake and reduced breast cancer risk( Reference Xu, Gammon and Zeisel 47 , Reference Xu, Gammon and Zeisel 48 ). Data from the Nurses’ Health Study indicated that women who had, during adolescence, a higher consumption of eggs had a significantly lower risk of breast cancer later in life( Reference Frazier, Ryan and Rockett 49 ). Another study( Reference Shannon, Ray and Wu 50 ) reported data from a case – control study of breast cancer incidence showing that egg consumption was significantly inversely associated with risk of breast cancer. The epigenetic effects of choline availability during prenatal and postnatal development are just beginning to be investigated( Reference Kovacheva, Davison and Mellott 51 , Reference Corbin and Zeisel 52 ).

Eggs also provide highly bioavailable forms of the xanthophylls lutein and zeaxanthin, which are related to lower risks for age-related macular degeneration and cataracts( Reference Chung, Rasmussen and Johnson 53 – Reference Wenzel, Gerweck and Barbato 56 ) as well as some types of cancer( Reference Huang, Zhang and Holman 57 – Reference Slattery, Benson and Curtin 59 ) and carotid artery atherosclerosis( Reference Dwyer, Navab and Dwyer 60 ). Eggs also provide satiety in the diet( Reference Vander Wal, Marth and Khosla 61 ) and can be a valuable addition to a low-energy weight-loss diet( Reference Vander Wal, Gupta and Khosla 62 ).

Restricting eggs in the diet can have negative consequences; and based on the available data, provides little benefit in terms of CVD risk reduction. It is essential that any food's value to health promotion/disease prevention be based on the totality of its nutrients and not just a single component.

Summary

For over 40 years the scientific community has debated the dietary cholesterol–blood cholesterol relationship and the rationale for restricting high-cholesterol foods, such as eggs, in the diet. Epidemiological surveys show that there is no relationship between dietary cholesterol intakes and either blood cholesterol levels or CVD risk between or within populations( Reference Rong, Chen and Zhu 19 – Reference Kritchevsky 21 ). The only group in which CVD risk has been associated with increased egg intake is the subpopulation with type II diabetes( Reference Hu, Stampfer and Rimm 13 , Reference Qureshi, Suri and Ahmed 15 , Reference Houston, Ding and Lee 63 ); however, this may relate to the degree of diabetic control in the study population, a factor that has not yet been controlled for in any of the published studies. Until this question is resolved there is justification in recommending that patients with type II diabetes limit their egg intake to <6 per week based on the available data.

Clinical studies form the basis of continued dietary cholesterol restrictions in some populations based on dietary cholesterol induced changes in total plasma cholesterol levels. However, considering the evidence that dietary cholesterol intake does not affect the LDL:HDL cholesterol ratio( Reference Fernandez and Webb 33 ) or the number of LDL particles( Reference Herron, Lofgren and Sharman 34 ), the change in total cholesterol levels does not reflect change in CVD risk. When the specific effects of dietary cholesterol on the atherogenicity of the plasma lipids is fully analysed, there is no conflict between the lack of effect of dietary cholesterol on CVD risk observed in epidemiological surveys and the small change in plasma cholesterol levels observed in clinical feeding studies.

The lack of evidence for a relationship between dietary cholesterol and heart disease risk is why most countries of the world do not specifically recommend dietary cholesterol restrictions( Reference Gray and Griffin 64 – Reference McNamara, Moghadasian and Eskin 66 ). In fact, in Canada and Australia, eggs carry the approval marking of their respective heart associations. Eggs provide several important nutrients that contribute to health promotion and disease prevention. First and foremost, eggs are an affordable source of high-quality protein, which for too many in the world is not a readily available nutrient due to either availability or prohibitive expense. For the elderly eggs are easy to cook, chew and digest and high-quality protein intake is related to a reduced rate of sarcopaenia( Reference Hsia, Otvos and Rossouw 38 ). Eggs can also play an important role in weight management due to their satiety effects( Reference McNamara, Moghadasian and Eskin 66 ). Eggs are a major source of choline, a nutrient that has been shown to be inadequate in the diet probably due to both egg restrictions and reduced overall fat intakes in many populations. Over the last two decades studies have shown the importance of choline in health promotion ranging from fetal brain development and epigenetics to reduced breast cancer morbidity and mortality. Eggs contain highly bioavailable xanthophylls important in eye health as well as other important health issues ranging from cancer to CVD( Reference McNamara, Moghadasian and Eskin 66 ). Given the available evidence, there is little rationale for recommending egg restrictions to the public. In fact, it seems that the only health risks associated with egg consumption are those associated with unnecessary and ineffectual restrictions on egg intake.

Acknowledgement

D. J. M. researched and wrote the manuscript. Opinions expressed are those of the author.

Financial support

This research received no financial support from any agency in the public, commercial or not-for-profit sectors.

Conflicts of interest

The author is the sole administrator of Eggs for Health Consulting which advises international egg associations on matters related to eggs and health issues.

Authorship

The author is solely responsible for all aspects of this paper preparation.

References

1. American Heart Association (1968) Diet and Heart Disease Risk. Dallas: American Heart Association.Google Scholar
2. Taubes, G (2007) Good Calories, Bad Calories. New York: Knopf.Google Scholar
3. Anitschkow, N & Chalatow, S (1913) Ueber experimentelle cholesterinsteatose und ihre bedeutung fur die entstehung einiger pathologischer prozesse. Zentralbl Allg Pathol Anat 24, 1–9.Google Scholar
4. Dietschy, JM (1984) Regulation of cholesterol metabolism in man and in other species. Klin Wochenschr 62, 338–345.Google Scholar
5. Fernandez, ML, Wilson, TA, Conde, K et al. (1999) Hamsters and guinea pigs differ in their plasma lipoprotein cholesterol distribution when fed diets varying in animal protein, soluble fiber, or cholesterol content. J Nutr 129, 1323–1332.Google Scholar
6. Fernandez, ML (2001) Guinea pigs as models for cholesterol and lipoprotein metabolism. J Nutr 131, 10–20.Google Scholar
7. Hegsted, DM & Ausman, LM (1988) Diet, alcohol and coronary heart disease in men. J Nutr 118, 1184–1189.CrossRefGoogle ScholarPubMed
8. Kromhout, D, Menotti, A, Bloemberg, B et al. (1995) Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 24, 308–315.Google Scholar
9. Ravnskov, U (1995) Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol 48, 713–719.Google Scholar
10. Lee, A & Griffin, B (2006) Dietary cholesterol, eggs and coronary heart disease risk in perspective. Br Nutr Found Nutr Bull 31, 21–27.Google Scholar
11. McNamara, DJ (2000) Dietary cholesterol and atherosclerosis. Biochim Biophys Acta 1529, 310–320.Google Scholar
12. Dawber, TR, Nickerson, RJ, Brand, FN et al. (1982) Eggs, serum cholesterol, and coronary heart disease. Am J Clin Nutr 36, 617–625.Google Scholar
13. Hu, FB, Stampfer, MJ, Rimm, EB et al. (1999) A prospective study of egg consumption and risk of cardiovascular disease in men and women. J Am Med Assoc 281, 1387–1394.CrossRefGoogle ScholarPubMed
14. Nakamura, Y, Iso, H, Kita, Y et al. (2006) Egg consumption, serum total cholesterol concentrations and coronary heart disease incidence: Japan public health center-based prospective study. Br J Nutr 96, 921–928.Google Scholar
15. Qureshi, AI, Suri, FK, Ahmed, S et al. (2007) Regular egg consumption does not increase the risk of stroke and cardiovascular diseases. Med Sci Monit 13, CR1–CR8.Google Scholar
16. Song, WO & Kerver, JM (2000) Nutritional contribution of eggs to American diets. J Am Coll Nutr 19, 556S–562S.CrossRefGoogle ScholarPubMed
17. Tillotson, JL, Bartsch, GE, Gorder, D et al. (1997) Food group and nutrient intakes at baseline in the multiple risk factor intervention trial. Am J Clin Nutr 65, Suppl., 228S–257S.Google Scholar
18. Scrafford, CG, Tran, NL, Barraj, LM et al. (2011) Egg consumption and CHD and stroke mortality: a prospective study of US adults. Public Health Nutr 14, 261–270.Google Scholar
19. Rong, Y, Chen, L, Zhu, T et al. (2013) Egg consumption and risk of coronary heart disease and stroke: dose–response meta-analysis of prospective cohort studies. BMJ 346, e8539.Google Scholar
20. Kritchevsky, SB & Kritchevsky, D (2000) Egg consumption and coronary heart disease: an epidemiologic overview. J Am Coll Nutr 19, 549S–555S.Google Scholar
21. Kritchevsky, SB (2004) A review of scientific research and recommendations regarding eggs. J Am Coll Nutr 23, 596S–600S.Google Scholar
22. McNamara, DJ (1999) Eggs, dietary cholesterol & heart disease risk: an international perspective. In Egg Nutrition and Biotechnology, pp. 55–63 [Sim, JS, Nakai, S and Guenter, W, editors]. New York: CABI Publishing.Google Scholar
23. Merchant, AT, Kelemen, LE, de Koning, L et al. (2008) Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis. Am J Clin Nutr 87, 168–174.Google Scholar
24. McNamara, DJ, Kolb, R, Parker, TS et al. (1987) Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity. J Clin Invest 79, 1729–1739.Google Scholar
25. McNamara, DJ (1990) Relationship between blood and dietary cholesterol. Adv Meat Res 6, 63–87.Google Scholar
26. McNamara, DJ (1987) Effects of fat-modified diets on cholesterol and lipoprotein metabolism. Annu Rev Nutr 7, 273–290.Google Scholar
27. Clarke, R, Frost, C, Collins, R et al. (1997) Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 314, 112–117.Google Scholar
28. Howell, WH, McNamara, DJ, Tosca, MA et al. (1997) Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 65, 1747–1764.Google Scholar
29. McNamara, DJ (2000). The impact of egg limitations on coronary heart disease risk: do the numbers add up? J Am Coll Nutr 19, 540S–548S.Google Scholar
30. Weggemans, RM, Zock, PL & Katan, MB (2001) Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr 73, 885–891.Google Scholar
31. Herron, KL, Vega-Lopez, S, Conde, K et al. (2002) Pre-menopausal women, classified as hypo- or hyperresponders, do not alter their LDL/HDL ratio following a high dietary cholesterol challenge. J Am Coll Nutr 21, 250–258.Google Scholar
32. Herron, KL, Vega-Lopez, S, Conde, K et al. (2003) Men classified as hypo- or hyperresponders to dietary cholesterol feeding exhibit differences in lipoprotein metabolism. J Nutr 133, 1036–1042.Google Scholar
33. Fernandez, ML & Webb, D (2008) The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr 27, 1–5.Google Scholar
34. Herron, KL, Lofgren, IE, Sharman, M et al. (2004) High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification. Metabolism 53, 823–830.Google Scholar
35. Williams, PT, Superko, HR, Haskell, WL et al. (2003) Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23, 314–321.Google Scholar
36. Fernandez, ML (2006) Dietary cholesterol provided by eggs and plasma lipoproteins in healthy populations. Curr Opin Clin Nutr Metab Care 9, 8–12.Google Scholar
37. Herron, KL & Fernandez, ML (2004) Are the current dietary guidelines regarding egg consumption appropriate? J Nutr 134, 187–190.Google Scholar
38. Hsia, J, Otvos, JD, Rossouw, JE et al. (2008) Women's Health Initiative Research Group. Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arterioscler Thromb Vasc Biol 28, 1666–1671.Google Scholar
39. Houston, DK, Nicklas, BJ, Ding, J et al. (2008) Health ABC Study. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the health, aging, and body composition (health abc) study. Am J Clin Nutr 87, 150–155.Google Scholar
40. Zeisel, SH (2006) Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 26, 229–250.Google Scholar
41. Yonemori, KM, Lim, U, Koga, KR et al. (2013) Dietary choline and betaine intakes vary in an adult multiethnic population. J Nutr 143, 894–899.Google Scholar
42. Zeisel, SH & Niculescu, MD (2006) Perinatal choline influences brain structure and function. Nutr Rev 64, 197–203.Google Scholar
43. Shaw, GM, Carmichael, SL, Yang, W et al. (2004) Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol 160, 102–109.Google Scholar
44. Shaw, GM, Finnell, RH, Blom, HJ et al. (2009) Choline and risk of neural tube defects in a folate-fortified population. Epidemiology 20, 714–719.Google Scholar
45. Detopoulou, P, Panagiotakos, DB, Antonopoulou, S et al. (2008) Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the Attica study. Am J Clin Nutr 87, 424–430.Google Scholar
46. Konstantinova, SV, Vollset, SE, Berstad, P et al. (2007) Dietary predictors of plasma total homocysteine in the Hordaland Homocysteine Study. Br J Nutr 98, 201–210.Google Scholar
47. Xu, X, Gammon, MD, Zeisel, SH et al. (2008) Choline metabolism and risk of breast cancer in a population-based study. FASEB J. 22, 2045–52.Google Scholar
48. Xu, X, Gammon, MD, Zeisel, SH et al. (2009) High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J. 23, 4022–4028.Google Scholar
49. Frazier, AL, Ryan, CT, Rockett, H et al. (2003) Adolescent diet and risk of breast cancer. Breast Cancer Res 5, R59–R64.Google Scholar
50. Shannon, J, Ray, R, Wu, C et al. (2005) Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 14, 81–90.Google Scholar
51. Kovacheva, VP, Davison, JM, Mellott, TJ et al. (2009) Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. FASEB J 23, 1054–1063.Google Scholar
52. Corbin, KD & Zeisel, SH (2012) The nutrigenetics and nutrigenomics of the dietary requirement for choline. Prog Mol Biol Transl Sci 108, 159–177.Google Scholar
53. Chung, HY, Rasmussen, HM & Johnson, EJ (2004) Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr 134, 1887–1893.Google Scholar
54. Goodrow, EF, Wilson, TA, Houde, SC et al. (2006) Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations. J Nutr 136, 2519–2524.Google Scholar
55. Ribaya-Mercado, JD & Blumberg, JB (2004) Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr 23, 567S–587S.Google Scholar
56. Wenzel, AJ, Gerweck, C, Barbato, D et al. (2006) A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women. J Nutr 136, 2568–2573.CrossRefGoogle ScholarPubMed
57. Huang, JP, Zhang, M, Holman, CD et al. (2007) Dietary carotenoids and risk of breast cancer in Chinese women. Asia Pac J Clin Nutr 16, Suppl. 1, 437–442.Google Scholar
58. Männistö, S, Yaun, SS, Hunter, DJ et al. (2007) Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am J Epidemiol 165, 246–255.Google Scholar
59. Slattery, ML, Benson, J, Curtin, K et al. (2000) Carotenoids and colon cancer. Am J Clin Nutr 71, 575–582.Google Scholar
60. Dwyer, JH, Navab, M, Dwyer, KM et al. (2001) Oxygenated carotenoid lutein and progression of early atherosclerosis: The Los Angeles Atherosclerosis Study. Circulation 103, 2922–2927.Google Scholar
61. Vander Wal, JS, Marth, JM, Khosla, P et al. (2005) Short-term effect of eggs on satiety in overweight and obese subjects. J Am Coll Nutr 24, 510–515.Google Scholar
62. Vander Wal, JS, Gupta, A, Khosla, P et al. (2008) Egg breakfast enhances weight loss. Int J Obes (Lond) 32, 1545–1551.Google Scholar
63. Houston, DK, Ding, J, Lee, JS et al. (2011) Health ABC Study. Dietary fat and cholesterol and risk of cardiovascular disease in older adults: the Health ABC Study. Nutr Metab Cardiovasc Dis 21, 430–437.Google Scholar
64. Gray, J & Griffin, B (2009) Eggs and dietary cholesterol – dispelling the myth. Nutrition Bulletin 34, 66–70.Google Scholar
65. McNamara, DJ (2009) Dietary cholesterol and blood cholesterolemia: a healthy relationship. World Rev Nutr Diet. 100, 55–62.Google Scholar
66. McNamara, DJ (2012) The impact of egg consumption in development or prevention of heart disease. In Functional Foods and Cardiovascular Disease pp. 179–197 [Moghadasian, MH and Eskin, NAM, editors]. Boca Raton: CRC Press.Google Scholar